Researchers identified new indicators for HER2+ breast cancer response to therapy
Being able to predict the response of cancer to treatment by analyzing a tumor sample before therapy is given would significantly affect clinical outcomes
Read More
Five tips to prevent or reduce cancer risks
Dr. Anthony Costales offers five tips to help women of all ages prevent or reduce their risk of various cancers.
Read More
Innovative surgical procedure reduces risk of lymphedema for breast cancer patients
Dr. Pabel Miah, Baylor Medicine breast surgeon, offers hope for improved postsurgical breast cancer outcomes.
Read More
Battling breast cancer while caring for patients
Nurse practitioner Line Hinojosa not only faces her own health battle but continues to care for patients, all while being a devoted mother.
Read More
Not just another breast cancer patient
Sandra Reyes’ experience with breast cancer is a testament to the power of surrounding yourself with the right support system.
Read More
Understanding breast cancer and imaging: when to consider an MRI, mammogram or ultrasound
Dr. Valentina Hoyos says early detection and diagnosis of breast cancer are crucial for effective treatment and improving survival rates.
Read More
PKMYT1, a potential ‘Achilles heel’ of treatment resistant ER+ breast cancers with the poorest prognosis
The challenge was to identify the kinase among hundreds of kinases in these treatment-resistant tumors that would help turn the tide in the fight against this cancer.
Read More
Baylor researchers awarded the National Academy of Sciences 2023 Cozzarelli Prize in Biomedical Sciences
The research warrants continuing investigations to translate the findings into a novel, more effective and longer-lasting cancer therapy.
Read More
Improving the detection of potential therapeutic tumor targets in human biopsies
The method holds great promise for better definition of the individual druggable landscape present in each cancer.
Read More
5D4 disrupts several molecular pathways, including MYC, that lead to cancer growth
The findings strongly support the potential use of TopBP1 inhibitors as a targeted cancer therapy.
Read More